[1]
Gu, J., Xu, S., Chen, X., Luo, H., Tan, G., Qi, W., Ling, F., Wang, C., Maimaiti, F., Chen, Y., Yang, L., Yin, M. and Chen, D. 2022. ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma. Bosnian Journal of Basic Medical Sciences. 22, 6 (Oct. 2022), 949–958. DOI:https://doi.org/10.17305/bjbms.2022.7268.